drug
Flublok
Marketedupdated 4mo agoby Protein Sciences Corp
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying Flublok
- phase3A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 With Influenza Vaccine in Adults ≥ 50 Years of Age
- phase3Immunogenicity Trial of 3 Influenza Vaccines
- —Flublok v. Standard Dose Vaccine Effectiveness Among Kaiser Permanente Northern California Adults 18-64 Years
- phase4Immunogenicity Trial of Egg- Versus Non-Egg-Based Influenza Vaccines Among HCP
- phase4Immunogenicity Trial of Recombinant Influenza Vaccine Among HCP in Israel
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that